Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -20.54 Million CAD | 19.52% |
| 2022 | -25.52 Million CAD | -3.3% |
| 2021 | -24.71 Million CAD | -30.64% |
| 2020 | -18.91 Million CAD | -55.21% |
| 2019 | -12.18 Million CAD | -82.89% |
| 2018 | -6.66 Million CAD | -27.94% |
| 2017 | -5.2 Million CAD | -58.71% |
| 2016 | -3.28 Million CAD | 25.77% |
| 2015 | -4.42 Million CAD | -64.58% |
| 2014 | -2.68 Million CAD | -157.04% |
| 2013 | -1.04 Million CAD | -10.93% |
| 2012 | -942.13 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.44 Million CAD | 13.23% |
| 2024 Q3 | -4.59 Million CAD | 15.65% |
| 2024 Q1 | -6.28 Million CAD | -75.32% |
| 2023 Q3 | -4.66 Million CAD | 28.34% |
| 2023 Q4 | -3.58 Million CAD | 23.17% |
| 2023 Q2 | -6.5 Million CAD | -12.25% |
| 2023 Q1 | -5.79 Million CAD | -6.27% |
| 2023 FY | -20.54 Million CAD | 19.52% |
| 2022 Q4 | -5.45 Million CAD | -4.2% |
| 2022 Q2 | -8.38 Million CAD | -32.8% |
| 2022 Q1 | -6.31 Million CAD | -6.03% |
| 2022 FY | -25.52 Million CAD | -3.3% |
| 2022 Q3 | -5.23 Million CAD | 37.61% |
| 2021 Q1 | -4.91 Million CAD | 26.8% |
| 2021 FY | -24.71 Million CAD | -30.64% |
| 2021 Q3 | -5.93 Million CAD | 24.93% |
| 2021 Q4 | -5.95 Million CAD | -0.32% |
| 2021 Q2 | -7.91 Million CAD | -60.86% |
| 2020 Q2 | -4.84 Million CAD | -52.58% |
| 2020 Q3 | -4.17 Million CAD | 13.91% |
| 2020 Q4 | -6.71 Million CAD | -61.05% |
| 2020 FY | -18.91 Million CAD | -55.21% |
| 2020 Q1 | -3.17 Million CAD | 25.81% |
| 2019 Q3 | -3.19 Million CAD | -44.46% |
| 2019 Q4 | -4.28 Million CAD | -33.85% |
| 2019 FY | -12.18 Million CAD | -82.89% |
| 2019 Q1 | -2.49 Million CAD | -33.22% |
| 2019 Q2 | -2.21 Million CAD | 11.26% |
| 2018 Q1 | -1.65 Million CAD | -42.97% |
| 2018 FY | -6.66 Million CAD | -27.94% |
| 2018 Q4 | -1.87 Million CAD | -34.08% |
| 2018 Q3 | -1.39 Million CAD | 19.56% |
| 2018 Q2 | -1.73 Million CAD | -4.73% |
| 2017 Q2 | -1.2 Million CAD | -20.55% |
| 2017 FY | -5.2 Million CAD | -58.71% |
| 2017 Q4 | -1.15 Million CAD | 31.64% |
| 2017 Q3 | -1.69 Million CAD | -41.29% |
| 2017 Q1 | -996.04 Thousand CAD | 28.54% |
| 2016 Q2 | -757.09 Thousand CAD | -99.05% |
| 2016 FY | -3.28 Million CAD | 25.77% |
| 2016 Q4 | -1.39 Million CAD | -85.74% |
| 2016 Q3 | -750.46 Thousand CAD | 0.88% |
| 2016 Q1 | -380.35 Thousand CAD | 41.62% |
| 2015 FY | -4.42 Million CAD | -64.58% |
| 2015 Q2 | -1.28 Million CAD | 20.1% |
| 2015 Q1 | -1.6 Million CAD | -81.99% |
| 2015 Q4 | -651.51 Thousand CAD | 26.03% |
| 2015 Q3 | -880.76 Thousand CAD | 31.35% |
| 2014 Q2 | -544.14 Thousand CAD | -75.06% |
| 2014 FY | -2.68 Million CAD | -157.04% |
| 2014 Q4 | -882.34 Thousand CAD | 7.03% |
| 2014 Q3 | -949.04 Thousand CAD | -74.41% |
| 2014 Q1 | -310.82 Thousand CAD | -12.43% |
| 2013 FY | -1.04 Million CAD | -10.93% |
| 2013 Q4 | -276.44 Thousand CAD | 21.83% |
| 2013 Q3 | -353.63 Thousand CAD | -53.85% |
| 2013 Q2 | -229.86 Thousand CAD | -24.14% |
| 2013 Q1 | -185.15 Thousand CAD | 0.0% |
| 2012 FY | -942.13 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AVITA Medical, Inc. | -40.4 Million USD | 49.146% |
| Manhattan Scientifics, Inc. | -703 Thousand USD | -2822.617% |
| Össur hf. | 87.46 Million USD | 123.492% |
| QHSLab, Inc. | -240.15 Thousand USD | -8455.201% |
| Wellstar International, Inc. | -1.79 Million USD | -1044.818% |
| Össur hf. | 87.46 Million USD | 123.492% |
| CVR Medical Corp. | - USD | Infinity% |
| Bionovate Technologies Corp | - USD | Infinity% |
| Escalon Medical Corp. | -104.47 Thousand USD | -19565.761% |
| Aurora Spine Corporation | -446.19 Thousand USD | -4504.703% |
| BrainsWay Ltd. | -4.92 Million USD | -317.008% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| BioElectronics Corporation | -274.29 Thousand USD | -7390.612% |
| Hamilton Thorne Ltd. | 277.99 Thousand USD | 7490.727% |
| Vivos Inc. | -2.79 Million USD | -635.586% |
| Kelyniam Global, Inc. | -239.16 Thousand USD | -8490.686% |
| REMSleep Holdings, Inc. | -1.77 Million USD | -1059.715% |
| Zecotek Photonics Inc. | -3.65 Million USD | -461.862% |
| Avitar, Inc. | 2.73 Million USD | 851.827% |
| Nanomix Corporation | -8.43 Million USD | -143.518% |
| EKF Diagnostics Holdings plc | 2.08 Million USD | 1087.314% |
| Theraclion SA | -3.48 Million USD | -490.25% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Positron Corporation | -1.36 Million USD | -1409.903% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | -2.06 Million USD | -894.992% |
| Lombard Medical, Inc. | -29.33 Million USD | 29.961% |
| ALR Technologies Inc. | -2.94 Million USD | -597.345% |
| Stratec SE | 25.26 Million USD | 181.311% |
| Vycor Medical, Inc. | 40.19 Thousand USD | 51220.898% |
| Heart Tronics, Inc. | 14.46 Million USD | 242.088% |
| MicroPort Scientific Corporation | -516.16 Million USD | 96.019% |
| VMS Rehab Systems, Inc. | -68.66 USD | -29924164.492% |
| NewCardio, Inc. | -9.45 Million USD | -117.206% |
| Guided Therapeutics, Inc. | -3.45 Million USD | -494.33% |
| Ingen Technologies, Inc. | -1.61 Million USD | -1173.268% |
| Odyssey Group International, Inc. | 14.26 Million USD | 244.07% |
| CYduct Diagnostics, Inc. | -378.9 Thousand USD | -5322.453% |
| Wellness Center USA, Inc. | -707.02 Thousand USD | -2805.967% |
| SANUWAVE Health, Inc. | -540 Thousand USD | -3704.815% |
| IR-Med Inc. | -4.91 Million USD | -318.367% |
| Perimeter Medical Imaging AI, Inc. | -20.72 Million USD | 0.886% |
| Polarean Imaging plc | -12.55 Million USD | -63.633% |
| United American Healthcare Corporation | -67 Thousand USD | -30565.672% |
| ECGI Holdings, Inc. | -407.48 Thousand USD | -4942.211% |
| Nu-Med Plus, Inc. | -120.52 Thousand USD | -16946.944% |
| Capital Group Holdings, Inc. | -634.68 Thousand USD | -3137.181% |
| ADM Tronics Unlimited, Inc. | -601.52 Thousand USD | -3315.675% |
| Medical Supply International USA, Inc. | 438.18 Thousand USD | 4788.941% |
| Urologix, Inc. | -6.93 Million USD | -196.479% |
| Rapid Therapeutic Science Laboratories, Inc. | -1.26 Million USD | -1526.333% |
| Nexeon MedSystems Inc. | -6.26 Million USD | -227.949% |
| SS Innovations International, Inc. | -20.66 Million USD | 0.592% |
| Qualis Innovations, Inc. | -230.24 Thousand USD | -8823.693% |
| Smith & Nephew plc | 425 Million USD | 104.834% |
| NIOX Group Plc | 4.6 Million USD | 546.652% |
| Fuse Medical, Inc. | 383.82 Thousand USD | 5453.03% |
| Broncus Holding Corporation | -33.22 Million USD | 38.154% |
| Brain Scientific Inc. | -9.6 Million USD | -113.834% |
| Pressure BioSciences, Inc. | -9.5 Million USD | -116.197% |
| Health Logic Interactive Inc. | -60.69 Thousand USD | -33748.993% |